ACON
Aclarion, Inc.Company Information
- Company Name
- Aclarion, Inc.
- CIK
- CIK0001635077
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ACON: Nasdaq, ACONW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- ACON
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-12
- Last sale
- —
- Shares purchased (TTM)
- 16,025
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 112,575
- Shares outstanding
- 2,129,871
- Ownership
- 5.29%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 2.13%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Cash And Cash Equivalents At Carrying Value | 16 | 19 | 12 | 11 | 13 | 15 | 0 | 1 | 1 | 2 | 1 | - | ||||||
| Restricted Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 17 | 19 | 12 | 12 | 13 | 15 | 1 | 2 | 2 | 3 | 1 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 18 | 21 | 14 | 13 | 15 | 16 | 2 | 3 | 3 | 4 | 2 | 2 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | ||||||
| Other Notes Payable Current | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | ||||||
| Common Stock Value | 0 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 81 | 81 | 71 | 69 | 69 | 69 | 52 | 52 | 50 | 49 | 44 | 42 | ||||||
| Stockholders Equity | 17 | 20 | 13 | 13 | 14 | 16 | 1 | 3 | 2 | 3 | -1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -64 | -61 | -58 | -57 | -55 | -53 | -51 | -49 | -48 | -47 | -44 | -43 | ||||||
| Liabilities And Stockholders Equity | 18 | 21 | 14 | 13 | 15 | 16 | 2 | 3 | 3 | 4 | 2 | 2 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 10 | 8 | 7 | 0 | 1 | ||||||
| Shares Outstanding | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 10 | 8 | 7 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAclarion, Inc. (ACON) — SEC Financial Statements & Analysis
Aclarion, Inc. (ACON) is a services-medical laboratories company, incorporated in DE. Aclarion, Inc. trades on Nasdaq as: ACON, ACONW. Aclarion, Inc. (ACON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Aclarion, Inc. carries a market cap of $7.09M, a P/E ratio of -0.77x, a P/B ratio of 0.42x, a P/S ratio of 84.65x, an enterprise value of $-9.22M, and an EV/EBITDA multiple of 0.97x. On profitability, it posts a gross margin of 21.75%, an operating margin of -11592.28%, a net margin of -10978.61%, a Return on Equity (ROE) of -58.97%, a Return on Assets (ROA) of -56.09%, and a Return on Invested Capital (ROIC) of -954.53%. Per share, it reports EPS of $-3.74, diluted EPS of $-3.74, free cash flow per share of $-3.31, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 33.07% year-over-year, net income growth of 30.26% year-over-year, and EPS growth of -69.19% year-over-year. On the balance sheet, it maintains a current ratio of 16.20x, a quick ratio of 15.77x, working capital of $15.76M, a debt-to-equity ratio of 0.06x, a debt ratio of 0.06, an interest coverage ratio of -16.42x, free cash flow of $-8.16M (TTM), and net debt of $-16.31M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.09M
- P/E TTM
- -0.77x
- EPS TTM
- $-3.74
- P/B TTM
- 0.42x
- ROE TTM
- -58.97%
- ROA TTM
- -56.09%
- Debt To Equity
- 0.06x
- Free Cash Flow TTM
- $-8.16M
- Net Revenue TTM Growth 1Y
- 33.07%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Aclarion, Inc. in?
Aclarion, Inc. (ACON) operates in the Services-Medical Laboratories industry.
What exchange does ACON trade on?
Aclarion, Inc. (ACON) trades on the Nasdaq.
Where is Aclarion, Inc. incorporated?
Aclarion, Inc. is incorporated in DE.
When was Aclarion, Inc. (ACON)'s most recent SEC filing?
Aclarion, Inc. (ACON)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is ACON's market cap?
Aclarion, Inc. (ACON) has a market capitalization of $7.09M as of 2026-06-30.
What is ACON's EPS (earnings per share)?
Aclarion, Inc. (ACON)'s trailing twelve month EPS is $-3.74 as of 2026-06-30.
What is ACON's ROE (return on equity)?
Aclarion, Inc. (ACON)'s trailing twelve month Return on Equity (ROE) is -58.97% as of 2026-06-30.
What is ACON's ROA (return on assets)?
Aclarion, Inc. (ACON)'s trailing twelve month Return on Assets (ROA) is -56.09% as of 2026-06-30.
What is ACON's ROIC (return on invested capital)?
Aclarion, Inc. (ACON)'s trailing twelve month Return on Invested Capital (ROIC) is -954.53% as of 2026-06-30.
What is ACON's EV/EBITDA?
Aclarion, Inc. (ACON)'s trailing twelve month EV/EBITDA is 0.97x as of 2026-06-30.